Skip to content

Elephas vs VitroScan

Elephas logo

Elephas

Live tumor profiling for immunotherapy response prediction

145 employees · est. 2020 · Madison, United States

VS
VitroScan logo

VitroScan

Predictive Testing Solutions

10 employees · est. 2016 · Leiden, The Netherlands

VitroScan is the older company (2020 vs 2016); Elephas is the larger of the two.

Side-by-Side Comparison

Elephas VitroScan
Founded
2020 2016 older
Headquarters
Madison, United States Leiden, The Netherlands
Employees
145 larger 10
Industry
AI, Biotechnology, Health Care Biopharma, Biotechnology, Health Care
Funding Stage
Series C Grant
Total Funding
$178.50M $2.70M
Funding Rounds
6 2
Services
Elephas Live Platform, Immunotherapy Response Prediction, Functional Testing of Live Tissue, Data Aggregation and Analysis Ex Vivo Micro-Tumor Predictive Testing, Insight-Driven Treatment Strategies, Clinical Trial Program Integration
Target Customers
Pathology Labs, Healthcare Providers, Cancer Researchers, Biotechnology Companies Clinicians, Cancer Patients, Pharmaceutical Companies, Biotech Firms, Oncology Researchers
Taxonomy
Ex-vivo PlatformTumor ProfilingImmunotherapy Response PredictionLive Patient BiopsiesTumor MicroenvironmentTumor Heterogeneity +8 3D Tumor TestingEx Vivo Drug TestingTumor MicroenvironmentTreatment PredictionPatient StratificationClinical Trials +9
Website
elephas.com vitroscan.com
Elephas logo

About Elephas

Elephas, founded in 2020 and headquartered in the United States, is making significant strides in the intersection of AI, Biotechnology, and Health Care. The company's slogan, "Live tumor profiling for immunotherapy response prediction," highlights its core innovation: an ex-vivo platform that analy...

VitroScan logo

About VitroScan

VitroScan, founded in 2016, is a pioneering Dutch biotech company, strategically located at the renowned Leiden Bio Science Park. The company aims to transform cancer treatment through its mission of “Predicting treatment outcome”. VitroScan has developed certified predictive ex vivo 3D tumor testi...

Also comparing in this category

Comparing more than these two?

Get Elephas, VitroScan and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Elephas compare?

A PDF of Elephas and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Elephas was founded in 2020, based in Madison, United States, with 145 employees. Elephas, founded in 2020 and headquartered in the United States, is making significant strides in the intersection of AI, Biotechnology, and Health Care. The company's slogan, "Live tumor profiling fo. VitroScan was founded in 2016, based in Leiden, The Netherlands, with 10 employees. VitroScan, founded in 2016, is a pioneering Dutch biotech company, strategically located at the renowned Leiden Bio Science Park. The company aims to transform cancer treatment through its mission of.
Elephas has raised $178.50M and VitroScan $2.70M. Latest stage: Elephas Series C, VitroScan Grant.
Both work in Biotechnology and Health Care and list tumor microenvironment among their focus areas.

Compare Elephas with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Elephas on 28 Jan 2026, and VitroScan on 4 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout